Skip to main content

Peer Review reports

From: Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest

Original Submission
21 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
8 Oct 2023 Reviewed Reviewer Report
17 Oct 2023 Reviewed Reviewer Report
8 Jan 2024 Author responded Author comments - Alice C. Fan
Resubmission - Version 3
8 Jan 2024 Submitted Manuscript version 3
7 Feb 2024 Author responded Author comments - Alice C. Fan
Resubmission - Version 4
7 Feb 2024 Submitted Manuscript version 4
9 Feb 2024 Author responded Author comments - Alice C. Fan
Resubmission - Version 5
9 Feb 2024 Submitted Manuscript version 5
6 Mar 2024 Reviewed Reviewer Report
16 Mar 2024 Author responded Author comments - Alice C. Fan
Resubmission - Version 6
16 Mar 2024 Submitted Manuscript version 6
Publishing
18 Mar 2024 Editorially accepted
16 Apr 2024 Article published 10.1186/s12885-024-12139-3

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us